We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Text Messaging Adherence to Stimulant Medication
Updated: 2/22/2017
Text Messaging Adherence to Stimulant Medication
Status: Enrolling
Updated: 2/22/2017
Text Messaging Adherence to Stimulant Medication
Updated: 2/22/2017
Text Messaging Adherence to Stimulant Medication
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
TOM: Testosterone in Older Men With Sarcopenia
Updated: 2/22/2017
Testosterone Replacement for Older Men With Sarcopenia
Status: Enrolling
Updated: 2/22/2017
TOM: Testosterone in Older Men With Sarcopenia
Updated: 2/22/2017
Testosterone Replacement for Older Men With Sarcopenia
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
TOM: Testosterone in Older Men With Sarcopenia
Updated: 2/22/2017
Testosterone Replacement for Older Men With Sarcopenia
Status: Enrolling
Updated: 2/22/2017
TOM: Testosterone in Older Men With Sarcopenia
Updated: 2/22/2017
Testosterone Replacement for Older Men With Sarcopenia
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
Updated: 2/23/2017
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
Status: Enrolling
Updated: 2/23/2017
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
Updated: 2/23/2017
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
Updated: 2/23/2017
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
Status: Enrolling
Updated: 2/23/2017
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
Updated: 2/23/2017
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
Updated: 2/23/2017
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
Status: Enrolling
Updated: 2/23/2017
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
Updated: 2/23/2017
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
Status: Enrolling
Updated: 2/23/2017
Click here to add this to my saved trials
Glutamate, Hyperarousal and Restless Legs Syndrome
Updated: 2/28/2017
Glutamate, Hyperarousal and Restless Legs Syndrome
Status: Enrolling
Updated: 2/28/2017
Glutamate, Hyperarousal and Restless Legs Syndrome
Updated: 2/28/2017
Glutamate, Hyperarousal and Restless Legs Syndrome
Status: Enrolling
Updated: 2/28/2017
Click here to add this to my saved trials
Glutamate, Hyperarousal and Restless Legs Syndrome
Updated: 2/28/2017
Glutamate, Hyperarousal and Restless Legs Syndrome
Status: Enrolling
Updated: 2/28/2017
Glutamate, Hyperarousal and Restless Legs Syndrome
Updated: 2/28/2017
Glutamate, Hyperarousal and Restless Legs Syndrome
Status: Enrolling
Updated: 2/28/2017
Click here to add this to my saved trials
PET Imaging in ALS Patients
Updated: 3/6/2017
Metabotropic Glutamate Receptor 5 (mGluR5) Imaging in Amyotrophic Lateral Sclerosis (ALS) Patients and Healthy Volunteers
Status: Enrolling
Updated: 3/6/2017
PET Imaging in ALS Patients
Updated: 3/6/2017
Metabotropic Glutamate Receptor 5 (mGluR5) Imaging in Amyotrophic Lateral Sclerosis (ALS) Patients and Healthy Volunteers
Status: Enrolling
Updated: 3/6/2017
Click here to add this to my saved trials
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
Updated: 3/7/2017
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/7/2017
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
Updated: 3/7/2017
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/7/2017
Click here to add this to my saved trials
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
Updated: 3/7/2017
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/7/2017
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
Updated: 3/7/2017
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/7/2017
Click here to add this to my saved trials
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
Updated: 3/7/2017
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/7/2017
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
Updated: 3/7/2017
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/7/2017
Click here to add this to my saved trials
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
Updated: 3/7/2017
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/7/2017
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
Updated: 3/7/2017
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/7/2017
Click here to add this to my saved trials
An In-home Study of Brain Computer Interfaces
Updated: 3/14/2017
An In-home Study of Brain Computer Interfaces
Status: Enrolling
Updated: 3/14/2017
An In-home Study of Brain Computer Interfaces
Updated: 3/14/2017
An In-home Study of Brain Computer Interfaces
Status: Enrolling
Updated: 3/14/2017
Click here to add this to my saved trials
Effect of Cenicriviroc on HIV Neurocognitive Impairment
Updated: 3/14/2017
Randomized, Placebo-Controlled, Double-Blind, Pilot Study of CCR5/CCR2 Inhibitor Cenicriviroc (CVC) for HIV Associated Neurocognitive Disorder (HAND)
Status: Enrolling
Updated: 3/14/2017
Effect of Cenicriviroc on HIV Neurocognitive Impairment
Updated: 3/14/2017
Randomized, Placebo-Controlled, Double-Blind, Pilot Study of CCR5/CCR2 Inhibitor Cenicriviroc (CVC) for HIV Associated Neurocognitive Disorder (HAND)
Status: Enrolling
Updated: 3/14/2017
Click here to add this to my saved trials
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Updated: 3/14/2017
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Status: Enrolling
Updated: 3/14/2017
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Updated: 3/14/2017
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Status: Enrolling
Updated: 3/14/2017
Click here to add this to my saved trials
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Updated: 3/14/2017
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Status: Enrolling
Updated: 3/14/2017
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Updated: 3/14/2017
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
Status: Enrolling
Updated: 3/14/2017
Click here to add this to my saved trials
Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis
Updated: 3/15/2017
Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis: A Phase 2a, Single-centered, Randomized, Placebo-controlled, Double-blind, Proof-of-concept Pilot Study.
Status: Enrolling
Updated: 3/15/2017
Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis
Updated: 3/15/2017
Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis: A Phase 2a, Single-centered, Randomized, Placebo-controlled, Double-blind, Proof-of-concept Pilot Study.
Status: Enrolling
Updated: 3/15/2017
Click here to add this to my saved trials
Placental Transfusion Project for Preterm Infants
Updated: 3/15/2017
Placental Transfusion in Preterm Infants Born at Less Than 34 Weeks of Gestation … Role of "Delayed" Cord Clamping and Umbilical Cord Milking
Status: Enrolling
Updated: 3/15/2017
Placental Transfusion Project for Preterm Infants
Updated: 3/15/2017
Placental Transfusion in Preterm Infants Born at Less Than 34 Weeks of Gestation … Role of "Delayed" Cord Clamping and Umbilical Cord Milking
Status: Enrolling
Updated: 3/15/2017
Click here to add this to my saved trials
Structural and Functional Brain Changes in Response to Post-Stroke Rehabilitation
Updated: 3/16/2017
Structural and Functional Brain Changes in Response to Post-Stroke Rehabilitation
Status: Enrolling
Updated: 3/16/2017
Structural and Functional Brain Changes in Response to Post-Stroke Rehabilitation
Updated: 3/16/2017
Structural and Functional Brain Changes in Response to Post-Stroke Rehabilitation
Status: Enrolling
Updated: 3/16/2017
Click here to add this to my saved trials
Pharmacological Intervention in Depression After Traumatic Brain Injury
Updated: 3/16/2017
Pharmacological Intervention in Depression After Traumatic Brain Injury (A Research Study Within the Traumatic Brain Injury Model System)
Status: Enrolling
Updated: 3/16/2017
Pharmacological Intervention in Depression After Traumatic Brain Injury
Updated: 3/16/2017
Pharmacological Intervention in Depression After Traumatic Brain Injury (A Research Study Within the Traumatic Brain Injury Model System)
Status: Enrolling
Updated: 3/16/2017
Click here to add this to my saved trials
Acute Cognitive and Neurobehavioral Intervention: Efficacy Evaluation
Updated: 3/16/2017
Acute Cognitive and Neurobehavioral Intervention: Efficacy Evaluation (a Research Project Within the Traumatic Brain Injury Model System Grant)
Status: Enrolling
Updated: 3/16/2017
Acute Cognitive and Neurobehavioral Intervention: Efficacy Evaluation
Updated: 3/16/2017
Acute Cognitive and Neurobehavioral Intervention: Efficacy Evaluation (a Research Project Within the Traumatic Brain Injury Model System Grant)
Status: Enrolling
Updated: 3/16/2017
Click here to add this to my saved trials
Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy
Updated: 3/20/2017
Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy Study 1. Phase I Study of Feasibility and Safety.
Status: Enrolling
Updated: 3/20/2017
Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy
Updated: 3/20/2017
Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy Study 1. Phase I Study of Feasibility and Safety.
Status: Enrolling
Updated: 3/20/2017
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Updated: 3/20/2017
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/20/2017
Click here to add this to my saved trials
Use of Repetitive Facilitative Exercise Program in Established Stroke
Updated: 3/21/2017
A Randomized Controlled Evaluation of a Repetitive Facilitative Exercise Program for Adults With an Established Stroke and Upper Extremity Impairment
Status: Enrolling
Updated: 3/21/2017
Use of Repetitive Facilitative Exercise Program in Established Stroke
Updated: 3/21/2017
A Randomized Controlled Evaluation of a Repetitive Facilitative Exercise Program for Adults With an Established Stroke and Upper Extremity Impairment
Status: Enrolling
Updated: 3/21/2017
Click here to add this to my saved trials
Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients
Updated: 3/21/2017
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Incobotulinumtoxin Type A for the Functional Improvement of Lower Extremity Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 3/21/2017
Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients
Updated: 3/21/2017
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Incobotulinumtoxin Type A for the Functional Improvement of Lower Extremity Spasticity in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 3/21/2017
Click here to add this to my saved trials
Pharmacokinetics of DMF and the Effects of DMF on Exploratory Biomarkers
Updated: 3/21/2017
An Open Label Study of the Pharmacokinetics of DMF and the Effects of DMF on Exploratory Biomarkers in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 3/21/2017
Pharmacokinetics of DMF and the Effects of DMF on Exploratory Biomarkers
Updated: 3/21/2017
An Open Label Study of the Pharmacokinetics of DMF and the Effects of DMF on Exploratory Biomarkers in Subjects With Secondary Progressive Multiple Sclerosis
Status: Enrolling
Updated: 3/21/2017
Click here to add this to my saved trials
Longitudinal Study of Outcomes Measures in ALS Trials
Updated: 3/22/2017
Longitudinal Study Comparing the Responsiveness of Outcomes Measures in ALS Trials
Status: Enrolling
Updated: 3/22/2017
Longitudinal Study of Outcomes Measures in ALS Trials
Updated: 3/22/2017
Longitudinal Study Comparing the Responsiveness of Outcomes Measures in ALS Trials
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Longitudinal Study of Outcomes Measures in ALS Trials
Updated: 3/22/2017
Longitudinal Study Comparing the Responsiveness of Outcomes Measures in ALS Trials
Status: Enrolling
Updated: 3/22/2017
Longitudinal Study of Outcomes Measures in ALS Trials
Updated: 3/22/2017
Longitudinal Study Comparing the Responsiveness of Outcomes Measures in ALS Trials
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Longitudinal Study of Outcomes Measures in ALS Trials
Updated: 3/22/2017
Longitudinal Study Comparing the Responsiveness of Outcomes Measures in ALS Trials
Status: Enrolling
Updated: 3/22/2017
Longitudinal Study of Outcomes Measures in ALS Trials
Updated: 3/22/2017
Longitudinal Study Comparing the Responsiveness of Outcomes Measures in ALS Trials
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Longitudinal Study of Outcomes Measures in ALS Trials
Updated: 3/22/2017
Longitudinal Study Comparing the Responsiveness of Outcomes Measures in ALS Trials
Status: Enrolling
Updated: 3/22/2017
Longitudinal Study of Outcomes Measures in ALS Trials
Updated: 3/22/2017
Longitudinal Study Comparing the Responsiveness of Outcomes Measures in ALS Trials
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Longitudinal Study of Outcomes Measures in ALS Trials
Updated: 3/22/2017
Longitudinal Study Comparing the Responsiveness of Outcomes Measures in ALS Trials
Status: Enrolling
Updated: 3/22/2017
Longitudinal Study of Outcomes Measures in ALS Trials
Updated: 3/22/2017
Longitudinal Study Comparing the Responsiveness of Outcomes Measures in ALS Trials
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Broad-spectrum Cognitive Remediation: Effects of a Brain Plasticity-based Program in Mild Traumatic Brain Injury
Updated: 3/27/2017
BRAVE Trial: Broad-spectrum Cognitive Remediation Available to Veterans: Effects of a Brain Plasticity-based Program in Mild Traumatic Brain Injury (mTBI)
Status: Enrolling
Updated: 3/27/2017
Broad-spectrum Cognitive Remediation: Effects of a Brain Plasticity-based Program in Mild Traumatic Brain Injury
Updated: 3/27/2017
BRAVE Trial: Broad-spectrum Cognitive Remediation Available to Veterans: Effects of a Brain Plasticity-based Program in Mild Traumatic Brain Injury (mTBI)
Status: Enrolling
Updated: 3/27/2017
Click here to add this to my saved trials
Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD
Updated: 3/28/2017
An Open-label, Single Ascending Dose, Pharmacokinetic and Tolerability Study of NFC-1 in Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 3/28/2017
Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD
Updated: 3/28/2017
An Open-label, Single Ascending Dose, Pharmacokinetic and Tolerability Study of NFC-1 in Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 3/28/2017
Click here to add this to my saved trials
Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD
Updated: 3/28/2017
An Open-label, Single Ascending Dose, Pharmacokinetic and Tolerability Study of NFC-1 in Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 3/28/2017
Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD
Updated: 3/28/2017
An Open-label, Single Ascending Dose, Pharmacokinetic and Tolerability Study of NFC-1 in Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 3/28/2017
Click here to add this to my saved trials
Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD
Updated: 3/28/2017
An Open-label, Single Ascending Dose, Pharmacokinetic and Tolerability Study of NFC-1 in Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 3/28/2017
Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD
Updated: 3/28/2017
An Open-label, Single Ascending Dose, Pharmacokinetic and Tolerability Study of NFC-1 in Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 3/28/2017
Click here to add this to my saved trials
Clinical Outcome Study for Dysferlinopathy
Updated: 3/29/2017
International Clinical Outcome Study for Dysferlinopathy
Status: Enrolling
Updated: 3/29/2017
Clinical Outcome Study for Dysferlinopathy
Updated: 3/29/2017
International Clinical Outcome Study for Dysferlinopathy
Status: Enrolling
Updated: 3/29/2017
Click here to add this to my saved trials